Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: BarSeq of Tailocin Antagonism Pseudomonas Mutant Fitness Assays

PROVIDER: PRJNA642696 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12120307.fastq.gz	Fastqsanger.gz
	SRR12120308.fastq.gz	Fastqsanger.gz
	SRR12120309.fastq.gz	Fastqsanger.gz
	SRR12120310.fastq.gz	Fastqsanger.gz
	SRR12120311.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 52

Similar Datasets

Barcode sequencing of Saccharomyces cerevisiae deletion libraries, SYBARIS project

Project description:A systematic approach allowing the identification of the molecular way-of-action of novel potential drugs represents the golden-tool for drug-discovery. While high-throughput screening technologies of large libraries is now well established, the assessment of the drug targets and mechanism of action is still under development. Taking advantage of the yeast model Saccharomyces cerevisiae, we herein applied BarSeq, a Next Generation Sequencing-based method to the analysis of both haploinsufficiency and homozygous fitness effects of a novel antifungal drug ('089') compared to the well-known antifungal ketoconazole. '089' was a novel compound identified in during a screen for antifungal drugs, as it was showing fungicidal effects, and able to affect the yeast fitness at the mitochondrial level (Stefanini et al., 2010. (Dissection of the Effects of Small Bicyclic Peptidomimetics on a Panel of Saccharomyces cerevisiae Mutants;.J Biol Chem, 285: 23477-23485.) Integrative bioinformatic analysis of BarSeq, whole genome expression analysis and classical biological assays identified the target and cell pathways affected by the novel antifungal. Confirmation of the effects observed in the yeast model and in pathogenic fungi further demonstrated the reliability of the multi-sided approach and the novelty of the targets and way-of-action of the new class of molecules studied representing a valuable source of novel antifungals.

2016-04-30 | E-SYBR-6 | biostudies-arrayexpress

ChIP-seq of the R-tailocin locus-specific LexA-related regulator PrtR1, two H-NS-like proteins MvaT and MvaV and the cell cycle-associated protein ParB

Project description:A ChIP-seq was used to identify the binding regions of the R-tailocin locus-specific LexA-related regulator PrtR1, two H-NS-like proteins MvaT and MvaV and the cell cycle-associated protein ParB in a R-tailocin inducing condition (with mitomycin C) and a non-inducing condition. We used Pseudomonas protegens CHA0 mutants that produce the protein of interest with a C-terminal V5-tag (MvaT-V5, MvaV-V5, PrtR-V5 and ParB-V5). We used CHA0 wild type without tagged proteins as a negative control.

2025-04-01 | E-MTAB-14721 | biostudies-arrayexpress

Project description:TnSeq mapping and BarSeq quantification of Dickeya mutant fitness

| PRJNA692477 | ENA

Project description:TnSeq mapping and BarSeq quantification of Ralstonia mutant fitness

| PRJNA629015 | ENA

Pectobacterium carotovorum

Project description:TnSeq mapping and BarSeq quantification of Pectobacterium mutant fitness

| PRJNA706928 | ENA

Project description:TnSeq mapping and BarSeq quantification of Pectobacterium carotovorum mutant fitness

| PRJNA794069 | ENA

Project description:BarSeq quantification of Dickeya transposon mutant fitness in potato stem

| PRJNA772181 | ENA

Expression analysis of novel and known antifungal drugs using S. cerevisiae as a model

Project description:A systematic approach allowing the identification of the molecular way of action of novel potential drugs still represents the golden-tool for drug-discovery researchers. While high-throughput screening technologies of large libraries is now well established, the assessment of the drug targets and mechanism of action is still under development. Taking advantage of the yeast model Saccharomyces cerevisiae, we herein applied BarSeq, a Next Generation Sequencing based method to the analysis of both haploinsufficiency and homozygous fitness effects of a novel antifungal drug compared to the well-known antifungal, ketoconazole. Integrative bioinformatic analysis of BarSeq, whole genome expression analysis and classical biological assays identified the target and cell pathways affected by the novel antifungal. Confirmation of the effects observed in the yeast model as well as in pathogenic fungi further demonstrated the reliability of the multi-sided approach and the novelty of the targets and mode of action of the new class of molecules studied that thus represent a valuable source of novel antifungals.

2016-12-30 | GSE42418 | GEO

Pseudomonas fluorescens strain:WCS417

Project description:Pseudomonas fluorescens - Barseq other

| PRJNA373054 | ENA

Protecomics analysis of toxin-antitoxin system HigBA mutant in P.aeruginosa

Project description:Pseudomonas aeruginosa kill the host Drosophila melanogasger very rapidly due to bacteria fitness in vivo. However, mutant of antitoxin HigA has impaired virulence accompanying with loss of fitness. We suppose the free toxin HigB in higA mutant inhibits some proteins production as to be an RNase. To explore the mechanism of antitoxin HigA leading to bacteria fitness in Drosophila, we performed proteomics to analyze the differential proteins in higA mutant in vitro.

2025-09-21 | PXD060361 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data